Document is current

Any future updates will be listed below

Vorteil beim EGFR-mutierten NSCLC

Crossref DOI link: https://doi.org/10.1007/s15033-018-0933-8

Published Online: 2018-05-21

Published Print: 2018-06

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark